High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on firstline ART in Myanmar, 2005-2015

被引:33
|
作者
Kyaw, Nang Thu Thu [1 ]
Harries, Anthony D. [2 ,3 ]
Kumar, Ajay M. V. [2 ,4 ]
Oo, Myo Minn [1 ]
Kyaw, Khine Wut Yee [1 ]
Win, Than [5 ]
Aung, Thet Ko [1 ]
Min, Aung Chan [1 ]
Oo, Htun Nyunt [6 ]
机构
[1] Int Union TB & Lung Dis, Mandalay, Myanmar
[2] Int Union TB & Lung Dis, Paris, France
[3] London Sch Hyg & Trop Med, London, England
[4] Union Southeast Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India
[5] Natl HIV AIDS Program, Mandalay, Myanmar
[6] Natl HIV AIDS Program, Nay Pyi Taw, Myanmar
来源
PLOS ONE | 2017年 / 12卷 / 02期
关键词
1ST-LINE ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; OUTCOMES; CHALLENGES; GUIDELINES; MANAGEMENT; PREDICTORS;
D O I
10.1371/journal.pone.0171780
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background The number of people living with HIV on antiretroviral treatment (ART) in Myanmar has been increasing rapidly in recent years. This study aimed to estimate rates of virological failure on first-line ART and switching to second-line ART due to treatment failure at the Integrated HIV Care program (IHC). Methods Routinely collected data of all adolescent and adult patients living with HIV who were initiated on first-line ART at IHC between 2005 and 2015 were retrospectively analyzed. The cumulative hazard of virological failure on first-line ART and switching to second-line ART were estimated. Crude and adjusted hazard ratios were calculated using the Cox regression model to identify risk factors associated with the two outcomes. Results Of 23,248 adults and adolescents, 7,888 (34%) were tested for HIV viral load. The incidence rate of virological failure among those tested was 3.2 per 100 person-years follow-up and the rate of switching to second-line ART among all patients was 1.4 per 100 person-years follow-up. Factors associated with virological failure included: being adolescent; being lost to follow-up at least once; having WHO stage 3 and 4 at ART initiation; and having taken first-line ART elsewhere before coming to IHC. Of the 1032 patients who met virological failure criteria, 762 (74%) switched to second-line ART. Conclusions We found high rates of virological failure among one third of patients in the cohort who were tested for viral load. Of those failing virologically on first-line ART, about one quarter were not switched to second-line ART. Routine viral load monitoring, especially for those identified as having a higher risk of treatment failure, should be considered in this setting to detect all patients failing on first-line ART. Strategies also need to be put in place to prevent treatment failure and to treat more of those patients who are actually failing.
引用
收藏
页数:17
相关论文
共 38 条
  • [1] Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific
    Ross, J.
    Jiamsakul, A.
    Kumarasamy, N.
    Azwa, I
    Merati, T. P.
    Do, C. D.
    Lee, M. P.
    Ly, P. S.
    Yunihastuti, E.
    Nguyen, K., V
    Ditangco, R.
    Ng, O. T.
    Choi, J. Y.
    Oka, S.
    Sohn, A. H.
    Law, M.
    [J]. HIV MEDICINE, 2021, 22 (03) : 201 - 211
  • [2] Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
    Salvi, Sonali
    Raichur, Priyanka
    Kadam, Dileep
    Sangle, Shashikala
    Gupte, Nikhil
    Nevrekar, Neetal
    Patil, Sandesh
    Chavan, Amol
    Nimkar, Smita
    Marbaniang, Ivan
    Mave, Vidya
    [J]. BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [3] Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
    Sonali Salvi
    Priyanka Raichur
    Dileep Kadam
    Shashikala Sangle
    Nikhil Gupte
    Neetal Nevrekar
    Sandesh Patil
    Amol Chavan
    Smita Nimkar
    Ivan Marbaniang
    Vidya Mave
    [J]. BMC Infectious Diseases, 22
  • [4] High levels of viral repression, malnutrition and second-line ART use in adolescents living with HIV: a mixed methods study from Myanmar
    Murray, Jillian
    Whitehouse, Katherine
    Ousley, Janet
    Bermudez, Elkin
    Soe, Theint Thida
    Hilbig, Adelene
    Soe, Kyi Pyar
    Mon, Phyu Ei
    Tun, Kyaw Tint
    Ei, Win Le Shwe Sin
    Cyr, Joanne
    Deglise, Carole
    Ciglenecki, Iza
    [J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [5] High levels of viral repression, malnutrition and second-line ART use in adolescents living with HIV: a mixed methods study from Myanmar
    Jillian Murray
    Katherine Whitehouse
    Janet Ousley
    Elkin Bermudez
    Theint Thida Soe
    Adelene Hilbig
    Kyi Pyar Soe
    Phyu Ei Mon
    Kyaw Tint Tun
    Win Le Shwe Sin Ei
    Joanne Cyr
    Carole Deglise
    Iza Ciglenecki
    [J]. BMC Infectious Diseases, 20
  • [6] Rate and predictors of HIV virological failure among adults on first-line antiretroviral treatment in Dar Es Salaam, Tanzania
    Samizi, Florence George
    Panga, Onna Duuma
    Mulugu, Senga Sembuche
    Gitige, Catherine Gale
    Mmbaga, Elia John
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (06): : 853 - 860
  • [7] Brief communication: The rate of switching from first-line to second-line antiretroviral therapy among people living with HIV in Aden City, Yemen
    Al-Haidary, Naif Mohammed
    Radman, Enas Abobakr
    [J]. AIDS RESEARCH AND THERAPY, 2024, 21 (01):
  • [8] Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment
    Chawana, Tariro D.
    Gandhi, Monica
    Nathoo, Kusum
    Ngara, Bernard
    Louie, Alexander
    Horng, Howard
    Katzenstein, David
    Metcalfe, John
    Nhachi, Charles F. B.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 76 (01) : 55 - 59
  • [9] Retention in care and virological failure among adult HIV plus patients on second-line ART in Rwanda: a national representative study
    Nsanzimana, Sabin
    Semakula, Muhammed
    Ndahindwa, Vedaste
    Remera, Eric
    Sebuhoro, Dieudonne
    Uwizihiwe, Jean Paul
    Ford, Nathan
    Tanner, Marcel
    Kanters, Steve
    Mills, Edward J.
    Bucher, Heiner C.
    [J]. BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [10] Treatment modification after second-line failure among people living with HIV in Asia-Pacific
    Jiamsakul, Awachana
    Azwa, Iskandar
    Zhang, Fujie
    Yunihastuti, Evy
    Ditangco, Rossana
    Kumarasamy, Nagalingeswaran
    Ng, Oon Tek
    Chan, Yu-Jiun
    Ly, Penh Sun
    Choi, Jun Yong
    Lee, Man-Po
    Pujari, Sanjay
    Kiertiburanakul, Sasisopin
    Chaiwarith, Romanee
    Merati, Tuti Parwati
    Sangle, Shashikala
    Khusuwan, Suwimon
    Sim, Benedict Lh
    Avihingsanon, Anchalee
    Duy, Cuong
    Tanuma, Junko
    Ross, Jeremy
    Law, Matthew
    [J]. ANTIVIRAL THERAPY, 2020, 25 (07) : 377 - 387